Clinical Trials Logo

Human Volunteers clinical trials

View clinical trials related to Human Volunteers.

Filter by:

NCT ID: NCT01452425 Completed - Human Volunteers Clinical Trials

In Vivo Optical Spectroscopy Monitoring in a New Model of Muscular Compartment Syndrome

Start date: October 2011
Phase: Phase 1
Study type: Interventional

Muscular compartment syndrome (MCS) is consecutive to an increase in intramuscular compartment pressures, and is a rare but serious postoperative complication. The INVOS (In Vivo Optical Spectroscopy) monitors tissular oxygenation continuously and non-invasively. The objective is to develop a model mimicking the physiopathology of MCS to assess the interest of the INVOS in this case.

NCT ID: NCT01445860 Completed - Human Volunteers Clinical Trials

Drug-Drug Interaction Study Of Effect Of PF-03882845 On Simvastatin Pharmacokinetics

Start date: August 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to estimate the effect of multiple oral doses of PF-03882845 on the pharmacokinetics of simvastatin and simvastatin acid in healthy, adult subjects.

NCT ID: NCT01437033 Completed - Human Volunteers Clinical Trials

Breath Test for Chemicals (Volatile Organic Compounds)

Start date: August 29, 2011
Phase:
Study type: Observational

Background: - Some types of cancer, like cancer of the esophagus, are difficult to detect at an early stage. A possible detection method involves collecting breath samples to look for chemicals that may be signs of cancer. However, more research is needed to determine how different chemicals appear in different breath samples. This study will involve healthy volunteers. Objectives: - To study chemicals appearing in breath samples of healthy volunteers. Eligibility: - Healthy volunteers between 30 and 60 years of age. Design: - Participants will fast overnight (midnight to morning) and then provide two breath samples taken 5 minutes apart. - Breath samples will be collected on days 1, 49, and 98 of the study

NCT ID: NCT00752466 Completed - Migraine Clinical Trials

A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or Separately

Start date: March 2003
Phase: Phase 1
Study type: Interventional

The primary purpose of this open-label study is to determine if concomitant therapy with topiramate and flunarizine has any effect on the pharmacokinetics of either drug. Safety will be assessed for all subjects, for the entire duration of the study.

NCT ID: NCT00744809 Completed - Human Volunteers Clinical Trials

TMC278-TiDP6-C152: A Study to Assess the Effects of TMC278 and Efavirenz (EFV) on the QT/QTc Interval (Heart Conduction and Heart Rhythm) in Healthy Volunteers.

Start date: August 2008
Phase: Phase 1
Study type: Interventional

This is a study to evaluate the effect of TMC278 25 mg daily on the QT/QTc interval (heart conduction and heart rhythm) in healthy volunteers. In a separate panel of healthy volunteers, the effect of efavirenz (EFV) 600 mg daily on the QT/QTc interval will be evaluated.

NCT ID: NCT00743977 Unknown status - Human Volunteers Clinical Trials

Bioequivalence of Phenazopyridine HCl in Healthy Volunteers

Start date: August 2008
Phase: N/A
Study type: Interventional

The present study aims at comparing the pharmacokinetics of the original formulation of phenazopyridine and a same generic product.

NCT ID: NCT00526968 Completed - Human Volunteers Clinical Trials

The Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain Function

Start date: September 2007
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the neurophysiological changes following single doses of EVT 101 using fMRI during rest and during cognitive tasks in young healthy male subjects.

NCT ID: NCT00254449 Completed - Human Volunteers Clinical Trials

Effect of NGX-4010 on ENFD and Sensory Function

Start date: November 2005
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate epidermal nerve fiber (ENF) regeneration and normalization of peripheral sensory nerve function over time in normal healthy volunteers following a 60 minute application of Capsaicin Dermal Patch (NGX 4010; capsaicin 640 mcg/cm2) as compared to comparable untreated skin areas (control).The objectives of this study are: 1) To assess the difference between patch-treated and comparable untreated skin areas (control) in ENFD as quantified by PGP 9.5 immunohistochemical staining of skin biopsy samples obtained at 1, 12 and 24 weeks following a 60 minute application; 2) To assess the difference between patch-treated and comparable untreated skin areas (control) for thermal detection thresholds as assessed by QST at 1, 12 and 24 weeks following a 60 minute application; and, 3) To assess the difference between patch-treated and comparable untreated skin areas (control) in mechanical (sharp pain) sensation and tactile threshold at 1, 12 and 24 weeks following a 60 minute application.

NCT ID: NCT00166933 Completed - Human Volunteers Clinical Trials

Minimal Erythema Dose of UV-B in Normal Population of Taiwan

Start date: June 2005
Phase: N/A
Study type: Observational

There is no previous study on the minimal erythema dose of UVB irradiation in Chinese people. We will investigate the correlation of skin phototype, constitutive skin color, facultative skin color and minimal erythema dose in Taiwanese.